Latest News
Lemonade Stock Tumbles 14% as Strong Revenue Growth Fails to Lift Profit Outlook
Lemonade (NYSE:LMND) shares dropped nearly 14% in premarket trading despite a 79% revenue surge, as the company held its full-year profit forecast steady, raising concerns about risk exposure and cash flow.
MARA Holdings Rises on Bitcoin Bounce, Energy Pivot in Focus
MARA Holdings (NASDAQ:MARA) edged toward $11 in premarket trading, tracking Bitcoin's rebound, as investors eye the company's energy pivot ahead of Q2 earnings on August 6.
2027 Social Security COLA Estimate Slashed to 3.7%, Reducing Benefit Payouts by $16.6 Billion
The projected 2027 Social Security cost-of-living adjustment has been reduced to 3.7%, down from 4.7%, trimming estimated benefit increases by $16.6 billion annually.
Medicare Part D Subsidy Phaseout Widens Insurer Pricing Gap
CMS plans to end temporary Part D assistance after 2026, with 2027 bids up 23.7%. Insurers like Centene face enrollment risk as pricing gaps widen.
Humana Stock Tumbles 8% Premarket Despite Strong Q2, 2026 Outlook Signals Sharp H2 Loss
Humana shares dropped 8% premarket despite Q2 earnings and revenue beats, as the 2026 adjusted EPS floor of $9 implies a second-half loss of $8.91 per share.
KLA Stock Tumbles 8.7% Premarket on Cash Flow Concerns Despite Record Revenue
KLA shares fell 8.7% premarket despite record revenue and upbeat guidance, as a 23.2% drop in free cash flow raised concerns about cash conversion.
Ondas Shares Dip Premarket as Order Conversion Takes Center Stage
Ondas Inc. shares slipped 1% premarket as investor attention turns from order momentum to execution, with four-week orders now 13.3% of the 2026 revenue goal.
Vertiv Shares Slide on Americas Revenue Miss Despite Strong Q4 Guidance
Vertiv shares dropped 10.9% in premarket trading after Q2 revenue missed estimates by 3.1%, though adjusted EPS and cash flow exceeded expectations. Q4 guidance implies 50% year-over-year sales growth.
Teradyne Surges on AI Test Demand, Margin Concerns Linger
Teradyne shares rose 7% premarket after Q3 guidance beat estimates by 20%, driven by AI demand. However, margin compression and a sharper earnings decline raise concerns.
AMIX Surges 54% on Cash Value Mismatch and Dilution Concerns
Autonomix Medical shares surged 54.5% premarket after a filing revealed cash per share was 91% above the closing price, but a massive warrant overhang and high burn rate pose risks.
Hermès Shares Tumble 10% on China Slowdown and Narrowing Growth
Hermès shares dropped nearly 10% after Q2 sales growth of 6.7% disappointed investors, as Asia ex-Japan slowed to 2.5%.